• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Astellas

Anonymous board for Astellas.
Replies
5
Views
14K
Replies
0
Views
2K
Replies
3
Views
4K
anonymous
Replies
22
Views
57K
anonymous
Replies
8
Views
15K
anonymous
Replies
0
Views
13K
anonymous
Replies
10
Views
29K
anonymous
Replies
7
Views
19K
anonymous
Replies
10
Views
27K
anonymous
Replies
37
Views
119K
anonymous
Replies
2
Views
22K
anonymous
Replies
6
Views
26K
anonymous
Replies
20
Views
50K
anonymous
Replies
4
Views
25K
anonymous
Replies
1
Views
25K
anonymous
Replies
10
Views
36K
anonymous
Replies
16
Views
43K
anonymous
Replies
0
Views
42K
anonymous